GerosMicro
Financial Marketplace
Investment & Growth Platform
Preparing your investment experience
Initializing platform... 00%
Arrowhead reports lower pancreatitis rates, early cholesterol drug results (ARWR:NASDAQ)
  • seekingalpha.com
  • Posted On 08 November 2026

Arrowhead reports lower pancreatitis rates, early cholesterol drug results (ARWR:NASDAQ)

Worsening blood-sugar control occurred in 14% of plozasiran recipients versus 8.7% on placebo. Overall health problems occurred at similar rates in both groups,...
Source: seekingalpha.com
Share Now

Live Support

We're here to help

CUSTOMER SUPPORT

Hello! How can we help you?

Send us a message and our Protocol Officer will assist you.

Connecting to support...